journal article·2019-12-04Open access

Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres

ZeWen Qiao, Zhi Yuan, Wenping Zhang, Daihao Wei, Ningmin Hu

Abstract

Osteomyelitis is difficult to treat because infective bone is poorly accessible for intravenously administering antibiotics and biofilm formation increases bacterial resistance. In this study, microspheres prepared using poly(lactide-co-glycolide) (PLGA) and embedded with moxifloxacin (MOX-PLGA microspheres) and rifampicin/moxifloxacin (RIF/MOX-PLGA microspheres) using the water-in-oil-in-water double emulsion solvent evaporation technique were used for local delivery. Shape of MOX-PLGA microspheres and RIF/MOX-PLGA microspheres were spherical, mean particle size of them were 20.52 μm and 16.62 μm, respectively. Encapsulation efficiency of the MOX-PLGA microspheres was 17.35% ± 2.42%. However, the encapsulation efficiency for MOX and RIF in RIF/MOX-PLGA microspheres was 33.25% ± 7.51% and 49.0% ± 11.25%, respectively. Moxifloxacin and rifampicin were released slowly from microspheres. Both microspheres can efficiently release antibiotics in vitro. Antibacterial and bacterial biofilm-inhibition properties of the released solution were investigated from RIF/MOX-PLGA, MOX-PLGA, and blank PLGA microspheres at varying time points in vitro. RIF/MOX-PLGA microspheres demonstrated the strongest antibacterial activity and bacterial biofilm-inhibition property than the other two microspheres (p < .05). This study suggests that the novel RIF/MOX-PLGA microspheres can be used as a promising carrier for osteomyelitis treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Antimicrobial agents and applications · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics, Xijing Hospital, Fourth Military Medical University

Department of Orthopedics, General Hospital of Ningxia Medical University

Department of Pharmacy, Institute of Clinical Pharmacology, General Hospital of Ningxia Medical University

General Hospital of Ningxia Medical University

Affiliated General Hospital, Ningxia Medical University

Funding

the Nature Science Foundation of Ningxia Province

References (42)

Show source-provided references
1. 10.1016/j.jconrel.2015.04.02210.1016/j.jconrel.2015.04.022 ↗
2. 10.1016/j.mehy.2017.06.02310.1016/j.mehy.2017.06.023 ↗
3. 10.1016/j.jor.2016.10.00410.1016/j.jor.2016.10.004 ↗
4. 10.1111/joim.1223310.1111/joim.12233 ↗
5. 10.1016/j.biomaterials.2015.12.01210.1016/j.biomaterials.2015.12.012 ↗
6. 10.1016/j.msec.2014.04.05510.1016/j.msec.2014.04.055 ↗
7. 10.1128/CMR.00134-1410.1128/CMR.00134-14 ↗
8. 10.3389/fmicb.2018.0258310.3389/fmicb.2018.02583 ↗
9. 10.1016/j.biotechadv.2016.09.00510.1016/j.biotechadv.2016.09.005 ↗
10. 10.1021/acsami.6b1491210.1021/acsami.6b14912 ↗
11. 10.1177/088532821662982310.1177/0885328216629823 ↗
12. 10.1016/j.actbio.2016.11.02810.1016/j.actbio.2016.11.028 ↗
13. 10.3109/21691401.2016.116163710.3109/21691401.2016.1161637 ↗
14. 10.1016/j.colsurfb.2017.07.03810.1016/j.colsurfb.2017.07.038 ↗
15. 10.3233/BME-17170310.3233/BME-171703 ↗
16. 10.1016/j.actbio.2014.06.01310.1016/j.actbio.2014.06.013 ↗
17. 10.1016/j.injury.2017.08.02110.1016/j.injury.2017.08.021 ↗
18. 10.1128/AAC.01822-1610.1128/AAC.01822-16 ↗
19. 10.1093/femspd/ftw01910.1093/femspd/ftw019 ↗
20. 10.1586/14787210.2015.99966910.1586/14787210.2015.999669 ↗
21. 10.1007/s00264-015-2819-210.1007/s00264-015-2819-2 ↗
22. 10.1016/j.ijantimicag.2017.01.04110.1016/j.ijantimicag.2017.01.041 ↗
23. Posadowska U, Brzychczy-Włoch M, Pamuła E, et al. Gentamicin loaded PLGA nanoparticles as local drug delivery system for the osteomyelitis treatment. Acta Bioeng Biomech. 2015;17:41–48.
24. 10.1007/s11095-012-0803-810.1007/s11095-012-0803-8 ↗
25. Visani J, Staals EL, Donati D. Treatment of chronic osteomyelitis with antibiotic-loaded bone void filler systems: an experience with hydroxyapatites calcium-sulfate biomaterials. Acta Orthop Belg. 2018;84:25–29.
26. 10.1007/s11095-017-2212-510.1007/s11095-017-2212-5 ↗
27. 10.1021/acsnano.6b0008710.1021/acsnano.6b00087 ↗
28. 10.1080/21691401.2016.123311010.1080/21691401.2016.1233110 ↗
29. 10.2147/DDDT.S13851010.2147/DDDT.S138510 ↗
30. 10.1016/j.jconrel.2012.03.02710.1016/j.jconrel.2012.03.027 ↗
31. 10.1007/s13346-016-0278-y10.1007/s13346-016-0278-y ↗
32. 10.1016/j.ijpharm.2016.01.02010.1016/j.ijpharm.2016.01.020 ↗
33. 10.1016/j.actbio.2010.12.01410.1016/j.actbio.2010.12.014 ↗
34. 10.1007/s10266-014-0187-910.1007/s10266-014-0187-9 ↗
35. 10.1016/j.msec.2015.09.05310.1016/j.msec.2015.09.053 ↗
36. 10.1016/j.biomaterials.2015.02.02010.1016/j.biomaterials.2015.02.020 ↗
37. 10.1093/jac/dkv37110.1093/jac/dkv371 ↗
38. 10.1016/j.actbio.2018.04.02410.1016/j.actbio.2018.04.024 ↗
39. 10.3390/ijms1208503910.3390/ijms12085039 ↗
40. 10.1016/j.ijantimicag.2014.11.01110.1016/j.ijantimicag.2014.11.011 ↗
41. 10.2147/DDDT.S13888810.2147/DDDT.S138888 ↗
42. 10.1002/jor.2319410.1002/jor.23194 ↗